Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

for
AL Amyloidosis, Amyloidosis
Location: Nashville TN, Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT05145816

Phase1, Phase2, Recruiting

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

for
Advanced or Metastatic Colorectal Cancer
Location: Nashville TN, Hattiesburg MS, Ann Arbor MI, Toronto,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05379595

Phase1, Phase2, Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for
Metastatic Colorectal Carcinoma,
Location: Nashville TN, Atlanta GA, Lexington KY, Indianapolis IN,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase3, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

for
Non-small Cell Lung Cancer
Location: Nashville TN, Elizabethtown KY, Knoxville TN,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase2, Phase3, Recruiting

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05501665

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

for
Sarcoma
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 0+

Code: NCT06482957

Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

for
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Location: Nashville TN, Birmingham AL, Dallas TX
Sponsor: Sonya Reid

Sex: All

Age: 18+

Code: NCT05693766

Phase2, Recruiting

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

for
Colorectal Cancer, Esophageal Cancer, Gastric Cancer,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT00899626

Recruiting

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

for
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06110572

Phase1, Phase2, Recruiting

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: Nashville TN, Springfield OH, Fort Wayne IN,
Sponsor: Luminate Medical, Inc.

Sex: All

Age: 18+

Code: NCT07142304

Recruiting

ETHAN - ET for Male BC

for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Nashville TN, Chapel Hill NC, Pittsburgh PA,
Sponsor: Jose Pablo Leone

Sex: Male

Age: 18+

Code: NCT05501704

Phase2, Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

for
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer,
Location: Nashville TN, Dallas TX
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05919108

Phase2, Recruiting

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

for
Retinoblastoma, Cancer Survivor, Biological Sibling,
Location: Nashville TN, Cincinnati OH, St Louis MO, Chicago IL,
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 0+

Code: NCT03932786

Recruiting

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Nashville TN, Columbus OH, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT04633239

Phase1, Recruiting

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for
Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer,
Location: Nashville TN, Fairfax VA, Irving TX, Houston TX,
Sponsor: Incendia Therapeutics

Sex: All

Age: 18+

Code: NCT05753722

Phase1, Recruiting

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

for
Breast Cancer, HER2-low Breast Cancer, Metastatic Breast Cancer,
Location: Nashville TN, Birmingham AL, Chapel Hill NC, Chicago IL,
Sponsor: Ana C Garrido-Castro, MD

Sex: All

Age: 18+

Code: NCT06533826

Phase2, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Nashville TN, Cincinnati OH, Roanoke VA, Fairfax VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

Inherited CAncer REgistry

for
Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT03231891

Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Nashville TN, Pittsburgh PA, Lee's Summit MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase1, Phase2, Recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Nashville TN, Cincinnati OH, Charlotte NC, Columbus OH,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase1, Recruiting